Search research articles
Contact Us
Filters
Showing results (121-130 of 147) with videos related to
Page
of 15
Sort By:
European Urology
|
July 5, 2016
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
J Alfred Witjes, Thierry Lebret, Eva M Compérat, et al.
BMC Cancer
|
July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer
Mathieu Rouanne, Julien Adam, Aïcha Goubar, et al.
World Journal of Urology
|
July 5, 2023
Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French Kidney Cancer Research Network (UroCCR 10)
Gaëlle Margue, Alexandre Ingels, Karim Bensalah, et al.
Cell Reports
|
December 3, 2014
Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes
Anne Biton, Isabelle Bernard-Pierrot, Yinjun Lou, et al.
Urologic Oncology
|
September 5, 2025
Peritoneal recurrence following nephrectomy for localized renal cancer: A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study-UroCCR 124)
Caroline Pettenati, Jean-Christophe Bernhard, Zine-Eddine Khene, et al.
European Urology
|
September 11, 2022
Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial
Martin Bögemann, Neal D Shore, Matthew R Smith, et al.
Oncogene
|
March 22, 2023
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
Hélène Neyret-Kahn, Jacqueline Fontugne, Xiang Yu Meng, et al.
European Urology
|
July 31, 2014
The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review
Harman M Bruins, Erik Veskimae, Virginia Hernandez, et al.
European Urology
|
June 28, 2023
Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand in FGFR3-mutated Tumors
Clarice S Groeneveld, Virginia Sanchez-Quiles, Florent Dufour, et al.
World Journal of Urology
|
July 22, 2023
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial
Thierry Lebret, Xavier Paoletti, Geraldine Pignot, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 147) with videos related to
Sort By:
Page
of 15
European Urology
|
July 5, 2016
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
J Alfred Witjes, Thierry Lebret, Eva M Compérat, et al.
BMC Cancer
|
July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer
Mathieu Rouanne, Julien Adam, Aïcha Goubar, et al.
World Journal of Urology
|
July 5, 2023
Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French Kidney Cancer Research Network (UroCCR 10)
Gaëlle Margue, Alexandre Ingels, Karim Bensalah, et al.
Cell Reports
|
December 3, 2014
Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes
Anne Biton, Isabelle Bernard-Pierrot, Yinjun Lou, et al.
Urologic Oncology
|
September 5, 2025
Peritoneal recurrence following nephrectomy for localized renal cancer: A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study-UroCCR 124)
Caroline Pettenati, Jean-Christophe Bernhard, Zine-Eddine Khene, et al.
European Urology
|
September 11, 2022
Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial
Martin Bögemann, Neal D Shore, Matthew R Smith, et al.
Oncogene
|
March 22, 2023
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
Hélène Neyret-Kahn, Jacqueline Fontugne, Xiang Yu Meng, et al.
European Urology
|
July 31, 2014
The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review
Harman M Bruins, Erik Veskimae, Virginia Hernandez, et al.
European Urology
|
June 28, 2023
Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand in FGFR3-mutated Tumors
Clarice S Groeneveld, Virginia Sanchez-Quiles, Florent Dufour, et al.
World Journal of Urology
|
July 22, 2023
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial
Thierry Lebret, Xavier Paoletti, Geraldine Pignot, et al.
Page
of 15